Quadramet Samarium 153 data

A postmarket trial of Quadramet in 114 patients with bone metastases demonstrated

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE